Sept 10 (Reuters) - Recce Pharmaceuticals Ltd RCE.AX :
* SELECTS AUSTRALIAN-BASED CMAX CLINICAL TRIAL FACILITY FOR PHASE I STUDY OF SYNTHETIC ANTIBIOTIC RECCE® 327
Sept 10 (Reuters) - Recce Pharmaceuticals Ltd RCE.AX :
* SELECTS AUSTRALIAN-BASED CMAX CLINICAL TRIAL FACILITY FOR PHASE I STUDY OF SYNTHETIC ANTIBIOTIC RECCE® 327